A
Angela M. Minassian
Researcher at University of Oxford
Publications - 68
Citations - 11967
Angela M. Minassian is an academic researcher from University of Oxford. The author has contributed to research in topics: Medicine & Vaccination. The author has an hindex of 25, co-authored 51 publications receiving 6156 citations. Previous affiliations of Angela M. Minassian include John Radcliffe Hospital & Nuffield Orthopaedic Centre.
Papers
More filters
Journal ArticleDOI
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002).
Amy Flaxman,N G Marchevsky,D Jenkin,J Aboagye,Parvinder K. Aley,Brian Angus,Sandra Belij-Rammerstorfer,S Bibi,M Bittaye,Federica Cappuccini,P Cicconi,Elizabeth A. Clutterbuck,Sophie Davies,Wanwisa Dejnirattisai,Christina Dold,Katie J. Ewer,P M Folegatti,Jamie Fowler,Adrian V. S. Hill,Simon Kerridge,Angela M. Minassian,Juthathip Mongkolsapaya,Yama F Mujadidi,Emma Plested,M N Ramasamy,Hannah Robinson,Helen Sanders,Emma V. Sheehan,Holly Smith,Matthew D. Snape,R Song,Danielle Woods,Gavin R. Screaton,Sarah C. Gilbert,Merryn Voysey,Andrew J. Pollard,Teresa Lambe,Syed Adlou,Robert Aley,Aabidah Ali,Rachel Anslow,Megan Baker,Phillip Baker,Jordan R. Barrett,Louise Bates,Kirsten Beadon,Rebecca Beckley,Jonathan Bell,D Bellamy,Amy Beveridge,Cameron Bissett,Luke Blackwell,Heather Bletchly,Amy Boyd,Alice Bridges-Webb,Charles H. Brown,Nicholas Byard,Susana Camara,Liliana Cifuentes Gutierrez,Andrea M. Collins,Rachel Cooper,Wendy E.M. Crocker,Thomas C. Darton,Hannah Davies,Judith Davies,Tesfaye Demissie,Claudio Di Maso,Tanya Dinesh,Francesca R. Donnellan,Alexander D. Douglas,Rachael Drake-Brockman,Christopher J A Duncan,Sean C. Elias,Katherine R. W. Emary,Mutjaba Ghulam Farooq,Saul N. Faust,Sally Felle,Daniela M. Ferreira,Carla Ferreira Da Silva,Adam Finn,Karen J. Ford,Emma Francis,Julie Furze,Michelle Fuskova,Eva P. Galiza,Ana Gibertoni Cruz,Leila Godfrey,Anna L. Goodman,Catherine M. Green,Christopher A Green,Nicola Greenwood,Daisy Harrison,Thomas C. Hart,Sophia Hawkins,Paul T. Heath,Helen Hill,Kushalinii Hillson,Bryn Horsington,Mimi M. Hou,E Howe,Nicola Howell,Carina Citra Dewi Joe,Elizabeth F Jones,Mwila Kasanyinga,Jade Keen,Sarah Kelly,David J. Kerr,Liaquat Khan,Baktash Khozoee,Jasmin Kinch,Patrick Kinch,Stanislava Koleva,Jonathan Kwok,Colin W. Larkworthy,Alison M. Lawrie,Rajeka Lazarus,Emily A. Lees,Grace Li,Vincenzo Libri,Patrick J. Lillie,Aline Linder,Fei Long,Raquel Lopez Ramon,Reece Mabbett,R Makinson,Spyridoula Marinou,Emma Marlow,Julia L. Marshall,O Mazur,Joanne McEwan,Alastair McGregor,Jolynne Mokaya,Ella Morey,Gertraud Morshead,Richard Morter,Jilly Muller,Philomena Mweu,Rabiullah Noristani,Nelly Owino,Marco Polo Peralta Alvarez,Abigail Platt,Katrina M Pollock,Ian D. Poulton,Samuel Provstgaard-Morys,David Pulido-Gomez,Matthew Rajan,Fernando Ramos Lopez,Adam J. Ritchie,Hannah Roberts,Christine S. Rollier,Indra Rudiansyah,Katherine Sanders,Jack E. Saunders,Samiullah Seddiqi,Hannah Sharpe,Robert Shaw,L Silva-Reyes,Nisha Singh,David J. Smith,Catherine C. Smith,Andrew Smith,Alexandra J. Spencer,Arabella Stuart,Rebecca K. Sutherland,Anna Szigeti,Karly Tang,Merin Thomas,Tonia M. Thomas,Amber Thompson,E. Thomson,Estée M. Török,Mark Toshner,Nguyen Tran,Rose Trivett,Iain Turnbull,Cheryl Turner,David P. J. Turner,Marta Ulaszewska,Iason Vichos,Laura L. Walker,Marion E. Watson,Conor Whelan,Rachel White,Sarah Williams,Chris Williams,Daniel B. Wright,Andy Yao +186 more
TL;DR: In this paper, the authors assessed the persistence of immunogenicity after a single dose of ChAdOx1 nCoV-19 (AZD1222), immunity after an extended interval (44-45 weeks) between the first and second dose, and response to a third dose as a booster given 28-38 weeks after the second dose.
Journal ArticleDOI
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial.
John Frater,Katie J. Ewer,A Ogbe,M Pace,S Adele,Emily Adland,J Alagaratnam,Parvinder K. Aley,Mohammed K. Ali,M A Ansari,A Bara,M Bittaye,S Broadhead,Anthony Brown,Harriet R. Brown,Federica Cappuccini,Cooney E,Wanwisa Dejnirattisai,Christina Dold,C Fairhead,H Fok,P M Folegatti,J Fowler,C Gibbs,Alissa Goodman,D Jenkin,Matthew Jones,R Makinson,N G Marchevsky,Yama F Mujadidi,H Nguyen,L Parolini,C Petersen,C Petersen,Emma Plested,Katrina M Pollock,M N Ramasamy,S Rhead,Hannah Robinson,N Robinson,P Rongkard,F Ryan,S Serrano,T Tipoe,Merryn Voysey,Anele Waters,P Zacharopoulou,Eleanor Barnes,Susanna Dunachie,P Goulder,Paul Klenerman,Gavin R. Screaton,Alan Winston,Alan Winston,Hill Avs.,Sarah C. Gilbert,Andrew J. Pollard,Sarah Fidler,Sarah Fidler,Julie Fox,Teresa Lambe,Watson Mee.,R Song,P Cicconi,Angela M. Minassian,S Bibi,Simon Kerridge,Nishanta Singh,Catherine M. Green,Alexander D. Douglas,Alison M. Lawrie,Elizabeth A. Clutterbuck +71 more
TL;DR: In this article, the safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in people living with HIV were investigated.
Journal ArticleDOI
Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Mycobacterium tuberculosis–infected Individuals
Clare R. Sander,Ansar A. Pathan,Natalie E. R. Beveridge,Ian D. Poulton,Angela M. Minassian,Nicola Alder,Johan Van Wijgerden,Adrian V. S. Hill,Fergus V. Gleeson,Robert J. O. Davies,Geoffrey Pasvol,Helen McShane +11 more
TL;DR: MVA85A is safe and highly immunogenic in individuals with LTBI and will facilitate further trials in TB-endemic areas.
Journal ArticleDOI
Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions
Ruth O. Payne,Sarah E. Silk,Sean C. Elias,Kazutoyo Miura,Ababacar Diouf,Francis Galaway,Hans de Graaf,Nathan J Brendish,Ian D. Poulton,O Griffiths,Nick J. Edwards,Jing Jin,Geneviève M. Labbé,Daniel G. W. Alanine,Loredana Siani,Stefania Di Marco,Rachel Roberts,N Green,Eleanor Berrie,Andrew S. Ishizuka,Carolyn M. Nielsen,Martino Bardelli,Frederica D. Partey,Frederica D. Partey,Frederica D. Partey,Michael F. Ofori,Lea Barfod,Juliana Wambua,Linda M. Murungi,Linda M. Murungi,Faith H. A. Osier,Sumi Biswas,James S. McCarthy,Angela M. Minassian,Rebecca Ashfield,Nicola K. Viebig,Fay L. Nugent,Alexander D. Douglas,Johan Vekemans,Gavin J. Wright,Saul N. Faust,Adrian V. S. Hill,Carole A. Long,Alison M. Lawrie,Simon J. Draper +44 more
TL;DR: This is the first time to the authors' knowledge that substantial RH5-specific responses have been induced by immunization in humans, with levels greatly exceeding the serum antibody responses observed in African adults following years of natural malaria exposure.
Journal ArticleDOI
Use of an automated blood culture system (BD BACTEC™) for diagnosis of prosthetic joint infections: easy and fast.
Angela M. Minassian,Angela M. Minassian,Robert Newnham,Elizabeth Kalimeris,Philip Bejon,Philip Bejon,Bridget L. Atkins,Bridget L. Atkins,Ian C. J. W. Bowler +8 more
TL;DR: Prolonged microbiological culture for 2 weeks is unnecessary when using BACTEC™ culture methods, and the majority of clinically significant organisms grow within 3 days, and Propionibacteria spp.